Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
4 strange cash-saving efforts biotechs are using to stay afloat
Biotech has always been a little unconventional, but, as the industry’s bear market drags on, efforts to stay afloat are reaching a whole new level.
Gabrielle Masson
,
Darren Incorvaia
Jun 20, 2025 6:00am
Seyltx gains option to boost cough pipeline with 8 NeurOp drugs
Jun 5, 2025 10:40am
Biogen blueprints $1B CNS deal with RNAi biotech
May 27, 2025 10:55am
Juri inks $210M T-cell engager deal with China biotech
May 27, 2025 6:00am
Genentech sticks 2nd molecular glue deal with Orionis worth $2B
May 21, 2025 8:30am
Revised Blueprint-VantAI deal turns focus to molecular glues
May 20, 2025 10:32am